These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10728963)

  • 41. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.
    Cice G; Tagliamonte E; Ferrara L; Iacono A
    Eur Heart J; 2000 Aug; 21(15):1259-64. PubMed ID: 10924316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 2001 Jun; 51(6):583-9. PubMed ID: 11422018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Saatsaki M; Diakakis GF; Chlouverakis GI; Vardas PE
    Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
    Aygul N; Ozdemir K; Duzenli MA; Aygul MU
    Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
    Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
    JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
    J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
    Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of molsidomine on hemodynamics in patients with dilated cardiomyopathy].
    Hackl W; Frohner K; Podczek A; Unger G; Steinbach K
    Wien Klin Wochenschr; 1986 Sep; 98(17):581-4. PubMed ID: 3765647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Activity of the autonomic nervous system in patients with congestive heart failure - is it worth evaluating?].
    Szydło K
    Kardiol Pol; 2009 Sep; 67(9):971-2. PubMed ID: 19938362
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
    Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
    Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heart failure in a district general hospital: are target doses of beta-blockers realistic?
    Mehta PA; McDonagh S; Poole-Wilson PA; Grocott-Mason R; Dubrey SW
    QJM; 2004 Mar; 97(3):133-9. PubMed ID: 14976270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of the effectiveness of long-term beta blocker treatment for dilated cardiomyopathy by signal averaged electrocardiography.
    Yamada T; Fukunami M; Shimonagata T; Kumagai K; Kim J; Sanada S; Ogita H; Hori M; Hoki N
    Heart; 1998 Mar; 79(3):256-61. PubMed ID: 9602659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new method using pulmonary gas-exchange kinetics to evaluate efficacy of beta-blocking agents in patients with dilated cardiomyopathy.
    Taniguchi Y; Ueshima K; Chiba I; Segawa I; Kobayashi N; Saito M; Hiramori K
    Chest; 2003 Sep; 124(3):954-61. PubMed ID: 12970023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.